References

A pan-cancer single-cell RNA-seq atlas of intratumoral B cells

10.1016/j.ccell.2024.09.011 · 2024 · External reference

Pan-cancer single-cell dissection reveals phenotypically distinct B cell subtypes

10.1016/j.cell.2024.06.038 · 2024 · External reference

A blueprint for tumor-infiltrating B cells across human cancers

10.1126/science.adj4857 · 2024 · External reference

Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade

10.1038/s41591-025-04177-6 · 2026 · External reference

Tumor-infiltrating plasma cell profiling after PD-1 blockade reveals tumor-specific antibodies

10.1016/j.ccell.2026.07.001 · 2026 · External reference

Tumor-draining lymph nodes in ovarian cancer lack germinal centers but harbor tumor-reactive memory B cells clonally linked to intra-tumoral B cells

10.1016/j.immuni.2026.04.017 · 2026 · External reference

Functional role of skull lymphoid structures in CNS immunosurveillance

10.1038/s41586-026-10951-4 · 2026 · External reference

The efficacy of immunotherapy in glioma requires distal B cell responses in tumor-draining lymph nodes

10.1126/sciimmunol.adz2494 · 2026 · External reference

Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer

10.1016/j.immuni.2022.02.001 · 2022 · External reference

Infiltrating plasma cells maintain glioblastoma stem cells through IgG-tumor binding

10.1016/j.ccell.2024.12.006 · 2025 · External reference

Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression

10.1038/s43018-021-00232-6 · 2021 · External reference

GABA promotes resistance to immunotherapy in patients with TLS-positive tumors

10.1016/j.ccell.2026.06.006 · 2026 · External reference

Tumor-reactive antibodies evolve from non-binding and autoreactive precursors

10.1016/j.cell.2022.02.012 · 2022 · External reference